Infections specific to the perinatal period

P16_INFECTIONS_SPECIFIC_PERINA_PERIOD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P35-P39 Cause of death: ICD-10 — P35-P39 2 out of 7 registries used, show all original rules.	468
4. Check minimum number of events None	468
5. Include endpoints P16_CONGN_VIRAL_DISEA P16_BACTERIAL_SEPSIS_NEWBO P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA P16_OMPHA_NEWBO_W_WO_MILD_HAEMORRHAGE P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD	468
6. Filter based on genotype QC (FinnGen only)	415

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P
Name in latin: Infectiones temporis perinatalis specificae

NAME	P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	P16_CONGN_VIRAL_DISEA\|P16_BACTERIAL_SEPSIS_NEWBO\|P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA\|P16_OMPHA_NEWBO_W_WO_MILD_HAEMORRHAGE\|P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P3
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P3
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Infections specific to the perinatal period based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42413	17614	24798
Only index persons	19844	8095	11749
Unadjusted period prevalence (%)
Whole population	0.61	0.50	0.69
Only index persons	0.39	0.30	0.45
Median age at first event (years)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	415	234	181
Unadjusted period prevalence (%)	0.08	0.08	0.08
Median age at first event (years)	0.00	0.00	0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
438: Matched controls
4378

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P39.9

ICD-10 Finland

Infection specific to the perinatal period, unspecified

+∞

177.5

158

P36.90

ICD-10 Finland

Suspected bacterial sepsis of newborn

+∞

165.4

148

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

5.0

30.2

165

P22.1

ICD-10 Finland

Transient tachypnoea of newborn

7.5

28.5

P39.1

ICD-10 Finland

Neonatal conjunctivitis and dacryocystitis

+∞

26.3

P36.0

ICD-10 Finland

Sepsis of newborn due to streptococcus, group B

+∞

24.2

P36.99

ICD-10 Finland

Bacterial sepsis of newborn, unspecified

+∞

22.1

P07.3

ICD-10 Finland

Other preterm infants

4.2

21.4

165

P01.10

ICD-10 Finland

Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery

18.4

20.3

P22.0

ICD-10 Finland

Respiratory distress syndrome of newborn

11.5

13.2

P36.3

ICD-10 Finland

Sepsis of newborn due to other and unspecified staphylococci

+∞

12.6

P39.0

ICD-10 Finland

Neonatal infective mastitis

+∞

11.5

P39.4

ICD-10 Finland

Neonatal skin infection

+∞

11.5

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

3.0

8.2

125

P22.9

ICD-10 Finland

Respiratory distress of newborn, unspecified

6.3

7.9

WX722

NOMESCO Finland

PEEP

3.9

7.9

P02.7

ICD-10 Finland

Fetus and newborn affected by chorioamnionitis

45.8

7.7

P59.0

ICD-10 Finland

Neonatal jaundice associated with preterm delivery

3.8

7.6

ZX198

NOMESCO Finland

Other local administration

10.3

7.1

602

Kela drug reimbursment

Children's severe malnutrition

2.8

6.5

125

P38

ICD-10 Finland

Omphalitis of newborn with or without mild haemorrhage

70.8

6.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.1

6.4

P70.4

ICD-10 Finland

Other neonatal hypoglycaemia

3.1

6.3

P35.1

ICD-10 Finland

Congenital cytomegalovirus infection

+∞

6.3

P36.4

ICD-10 Finland

Sepsis of newborn due to Escherichia coli

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

575

1.76

5.12

5.1

4.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

6.74

2.87

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

140

1089

1.42

2.84

3.2

3.1

0.00

estimate

0.50

234

(3035350) Ketones [Presence] in Urine by Test strip

193

1598

1.37

2.67

4.0

3.7

0.00

5.72

estimate

0.50

284

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

7.21

2.55

1.2

1.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

190

1582

1.35

2.49

4.0

3.6

0.00

estimate

-0.00

290

(40768795) Lymph node Pathology biopsy report

4.43

2.48

1.1

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.86

2.47

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

192

1606

1.35

2.43

4.1

3.7

0.00

estimate

-0.00

282

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

3.08

2.37

1.4

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

121

1.95

2.25

4.0

4.8

7.72

10.71

e6/l

0.15

(3021589) Normoblasts [#/volume] in Blood

236

2055

1.32

2.19

10.7

12.0

0.00

0.01

e9/l

0.48

185

1574

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

358

1.55

2.18

2.2

2.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.04

2.15

1.0

1.1

—

(3018418) pH of Serum or Plasma

724

1.40

2.12

4.9

4.5

7.39

7.38

0.30

506

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.24

2.10

1.1

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

354

1.53

2.07

2.3

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

447

1.48

2.06

2.4

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

699

1.38

1.94

3.7

4.0

4.01

3.55

e6/l

0.10

359

(40761536) Microorganisms panel - Urine sediment

237

1.61

1.91

2.6

3.6

—

(3015736) pH of Urine

162

1360

1.30

1.89

3.8

3.3

6.43

6.37

0.27

647

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

378

3563

1.44

1.88

14.2

11.7

23.83

22.82

mg/l

0.24

276

2534

(3030467) Casts [#/volume] in Urine by Automated count

134

1098

1.32

1.86

4.3

4.4

0.24

0.21

e6/l

0.09

803

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.30

1.82

1.2

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

103

816

1.34

1.80

3.1

2.8

0.00

estimate

-0.00

232

(3002179) Metamyelocytes/Leukocytes in Blood

233

1.59

1.80

6.6

5.6

0.69

0.34

0.54

(3029937) Albumin [Presence] in Urine by Test strip

747

1.35

1.74

3.3

3.6

0.00

estimate

-0.00

278

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

146

1223

1.29

1.71

4.8

—

(3025159) Blasts/Leukocytes in Blood

245

1.56

1.69

7.0

6.2

0.15

0.00

0.78

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

180

1550

1.27

1.69

15.5

13.6

1.23

mmol/l

0.12

172

1486

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.21

1.68

1.9

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

343

3200

1.33

1.67

17.2

13.2

3.92

3.90

mmol/l

0.35

337

3096

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.92

1.67

1.5

2.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.61

1.66

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.01

1.66

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

372

1.45

1.66

19.1

22.0

1.16

1.05

mg/l

0.82

367

(3004588) Protein electrophoresis panel - Serum or Plasma

2.47

1.65

1.2

3.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.60

1.62

4.0

1.9

—

(3017181) Myelocytes/Leukocytes in Blood

249

1.53

1.58

6.6

6.2

0.92

0.55

0.37

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

554

1.36

1.52

4.1

4.9

4.36

1.40

mg/l

0.47

389

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.88

1.51

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.88

1.51

1.2

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.88

1.51

1.2

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

342

3205

1.30

1.50

17.2

13.2

139.45

139.51

mmol/l

0.27

336

3121

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

709

1.32

1.50

3.8

3.9

0.73

0.83

e6/l

0.13

368

(3007461) Platelets [#/volume] in Blood

415

4015

1.63

1.49

21.4

17.4

275.25

270.12

e9/l

0.77

394

3855

(3002582) Erythrocytes [#/volume] in Urine

140

1185

1.27

1.48

4.8

4.6

19.72

22.97

e6/l

0.14

892

(3021960) Folate [Moles/volume] in Serum or Plasma

575

1.34

1.47

1.7

1.5

18.19

18.52

nmol/l

0.09

513

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.52

1.45

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.52

1.45

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.52

1.45

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.33

1.43

1.1

1.0

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

415

4019

1.61

1.43

21.2

17.2

86.49

86.39

0.15

408

3960

(3026361) Erythrocytes [#/volume] in Blood

415

4020

1.61

1.42

21.3

17.3

4.62

4.64

e12/l

0.31

394

3850

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

415

4020

1.61

1.42

22.8

18.4

39.57

40.79

0.78

408

3962

(3035941) MCH [Entitic mass]

415

4020

1.61

1.42

21.3

17.2

28.99

29.02

0.14

408

3962

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

166

1.60

1.40

11.5

14.2

0.63

0.62

0.02

166

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.43

1.39

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.10

1.39

1.3

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

127

1.69

1.39

6.2

5.0

10.41

12.19

umol/l

0.18

109

(3000963) Hemoglobin [Mass/volume] in Blood

415

4022

1.60

1.39

21.6

17.5

133.18

134.10

g/l

0.70

408

3967

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

2.22

1.37

1.4

1.6

480.78

315.72

pmol/l

—

(3000492) Spirometry study

300

1.44

1.37

1.6

1.4

—

(3010813) Leukocytes [#/volume] in Blood

415

4023

1.59

1.37

21.3

17.3

6.69

6.71

e9/l

0.06

394

3851

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.63

1.37

1.3

1.0

—

(3037121) Protein [Mass/volume] in Urine

208

1.53

1.37

4.6

9.2

151.46

332.79

mg/l

2.95

163

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.96

1.36

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.96

1.36

1.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

2.96

1.36

2.2

20.8

—

(40761535) Cells panel - Urine sediment

136

1.65

1.35

3.3

3.9

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

1.34

0.0

1.2

—

32.17

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

1.34

0.0

1.2

—

18.09

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.76

1.32

1.5

2.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

363

3447

1.31

19.5

16.1

13.26

13.08

1.81

357

3396

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.52

1.30

1.3

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

115

1.68

1.26

4.6

4.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

811

1.27

1.24

5.3

5.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

187

1662

1.22

1.23

13.6

12.1

1.23

1.22

mmol/l

0.81

176

1532

(3002256) Pathology report gross observation

247

1.45

1.23

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

2.18

1.22

1.1

1.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

121

1029

1.24

1.21

3.6

3.5

2.55

2.50

mg/l

0.11

111

916

(3027273) Bicarbonate [Moles/volume] in Venous blood

109

1.68

1.20

4.7

7.5

25.03

24.16

mmol/l

0.49

103

(3018095) Leukocytes [#/volume] in Urine

162

1422

1.22

1.20

6.0

5.4

43.41

54.21

e6/l

0.21

931

(3032080) INR in Blood by Coagulation assay

805

1.26

1.20

6.1

5.8

1.13

1.17

inr

0.28

683

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

141

1.59

1.19

2.3

2.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

486

1.32

1.18

1.5

265.43

504.50

u/ml

0.67

456

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

166

1.54

1.17

3.6

4.3

—

(4034850) Laboratory test

2.07

1.15

6.6

8.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2.07

1.15

1.1

1.7

—

(3021440) Promyelocytes/Leukocytes in Blood

242

1.44

1.15

6.9

6.2

0.00

0.04

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

1.15

0.0

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.52

1.15

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.52

1.15

1.0

1.1

—

(40761511) CBC panel - Blood by Automated count

372

3560

1.30

1.14

10.1

8.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

104

878

1.24

1.11

3.8

2.8

2.39

2.40

mmol/l

0.28

822

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

2.28

1.10

1.1

1.3

0.39

0.40

nmol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

103

870

1.24

1.09

1.8

1.6

95.89

98.02

pmol/l

0.18

459

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

169

1.51

1.09

1.7

1.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.40

1.09

1.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.40

1.09

1.0

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

220

1.44

1.08

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.67

1.08

2.5

2.1

—

64.57

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

566

1.28

1.07

1.9

1.7

—

(3022313) Gas panel - Capillary blood

631

1.27

1.06

10.0

9.3

—

(3019150) Specific gravity of Urine by Refractometry

827

1.24

1.05

3.1

2.9

1.10

1.02

kg/l

0.50

505

(3013650) Neutrophils [#/volume] in Blood by Automated count

253

2339

1.19

1.04

11.0

11.4

3.34

3.46

e9/l

0.47

210

1945

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.29

1.03

21.2

3.1

5.00

4.95

kpa

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

1.03

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.29

1.03

1.2

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2.07

1.03

1.0

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

139

1.54

1.02

2.6

4.2

64.33

79.74

ml/min/173m2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

2.01

1.00

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

190

1.45

0.99

2.9

2.4

65.51

99.80

au/ml

0.74

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.85

0.99

2.1

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

124

1.56

0.98

2.4

1.6

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

2.19

0.98

1.0

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.19

0.98

1.0

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.19

0.98

1.0

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

347

1.33

0.98

2.3

2.4

6.44

5.49

u/l

0.55

214

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

4.7

—

207.71

—

(40768441) Liver Pathology biopsy report

1.96

0.97

2.1

2.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

149

1.50

0.97

2.5

2.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.79

0.95

1.2

—

(3001604) Monocytes [#/volume] in Blood

239

2210

1.18

0.94

9.0

9.8

0.54

0.55

e9/l

0.15

201

1837

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

159

1.47

0.93

3.3

2.3

—

(3000991) Gas panel - Venous blood

717

1.23

0.92

12.2

13.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

280

1.35

0.92

2.4

2.0

179.65

162.32

u/ml

0.15

123

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.16

0.92

1.5

2.1

2.14

4.69

mg/l

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.16

0.92

2.2

32.33

31.68

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.16

0.92

1.5

2.1

2.39

6.16

mg/l

—

(3044941) Cell count panel - Synovial fluid

2.16

0.92

1.2

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.08

0.89

1.5

2.1

1.18

1.07

mg/l

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.71

0.89

1.9

1.5

—

(3045142) Bone marrow Pathology biopsy report

1.92

0.89

1.4

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

212

1.39

0.88

1.1

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

135

1196

1.19

0.88

8.1

18.50

18.64

umol/l

0.01

124

1106

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

120

1.52

0.86

4.6

3.54

3.32

mmol/l

0.55

115

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.83

0.86

1.9

1.3

—

(3026008) Bacteria identified in Urine by Culture

817

1.21

0.86

3.1

2.4

—

(3023410) Appearance of Cerebral spinal fluid

1.58

0.85

5.5

5.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

284

1.33

0.85

2.4

2.0

—

62.01

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

138

0.57

0.84

1.1

—

6.33

—

(3009343) pH of Capillary blood

734

1.21

0.84

12.0

9.3

7.40

7.41

0.24

599

(42870588) Differential panel, method unspecified - Blood

180

1639

1.17

0.84

9.8

10.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

727

1.21

0.81

11.8

9.3

1.36

0.87

mmol/l

0.67

516

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.71

0.81

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

216

1999

1.16

0.80

8.0

6.1

121.64

114.40

u/l

0.62

198

1892

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

168

1527

1.16

0.79

4.7

3.7

67.49

65.76

nmol/l

0.39

163

1446

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

107

1212

0.84

0.79

4.5

3.4

—

estimate

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.79

0.0

2.4

—

(3006315) Basophils [#/volume] in Blood

237

2212

1.15

0.78

9.1

9.8

0.04

e9/l

1.03

199

1841

(44790049) Parainfluenza type 3 nucleic acid detection

115

1.50

0.78

2.6

2.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

115

1.50

0.78

2.6

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

115

1.50

0.78

2.2

4.5

190.55

160.60

e6/l

0.16

(44790047) Parainfluenza type 1 nucleic acid detection

115

1.50

0.78

2.6

2.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

115

1.50

0.78

2.6

2.2

—

(3022145) Colonoscopy Study observation

192

1.38

0.77

1.6

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

192

1.38

0.77

2.9

2.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

361

1.27

0.76

1.3

277.58

136.85

u/ml

—

107

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.76

0.0

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.71

0.76

8.2

3.3

1.36

1.43

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.71

0.76

1.7

1.5

5.48

10.41

u/l

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

231

2155

1.15

0.75

3.4

3.2

4.27

4.31

mmol/l

0.31

221

2063

(3002030) Lymphocytes/Leukocytes in Blood

233

2177

1.15

0.74

9.5

9.9

35.18

34.55

0.35

228

2093

(1002224) Polysomnography panel

1.85

0.74

1.3

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

159

0.62

0.73

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

228

2128

1.15

0.73

3.4

3.1

2.58

mmol/l

0.04

218

2019

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.01

0.73

26.4

5.3

1.23

1.22

mmol/l

—

(3012516) Albumin [Mass/volume] in Urine

328

1.28

0.72

4.1

4.3

54.69

70.66

mg/l

0.25

271

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

301

1.29

0.72

1.5

532.10

25094066.15

pmol/l

0.50

267

(21494434) Karyotype in Bone marrow

1.76

0.71

1.6

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.93

0.71

1.2

1.9

—

(3021788) Differential panel - Synovial fluid

1.93

0.71

1.2

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

116

0.60

0.69

2.6

2.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.68

0.68

1.0

—

(3013115) Eosinophils [#/volume] in Blood

242

2276

1.14

0.68

9.8

10.4

0.19

0.21

e9/l

1.11

207

1940

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.53

0.66

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.55

0.66

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

240

2259

1.14

0.66

9.0

9.7

2.26

2.25

e9/l

0.05

207

1937

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

876

1.17

0.66

1.9

2.0

1.37

1.16

mmol/l

0.39

822

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

302

0.75

0.65

1.2

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

146

1.39

0.64

13.9

8.6

22.64

23.34

mmol/l

0.68

140

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

225

2112

1.13

0.64

3.3

3.0

1.36

1.42

mmol/l

1.63

215

2006

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.64

0.62

6.9

9.2

2.58

2.33

mg/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.67

0.61

3.8

2.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

138

0.64

0.61

1.1

1.4

—

(40768804) Tissue Pathology biopsy report

740

0.84

0.61

1.5

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.59

0.0

2.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

293

2804

1.13

0.59

4.1

3.7

14.39

14.44

pmol/l

0.12

263

2500

(3026782) Osmolality of Urine

732

1.16

0.58

3.1

3.5

500.31

600.55

mosm/kgh2o

3.14

649

(3012544) pH of Venous blood

790

1.16

0.57

11.8

10.6

7.37

0.20

556

(4035726) Immunohistochemistry procedure

176

1.32

0.57

1.9

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.44

0.57

1.4

3.7

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

243

2303

1.12

0.57

4.7

4.8

8.47

6.80

mm/h

1.28

229

2165

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.67

0.57

11.3

8.7

—

(3019060) Gas panel - Arterial blood

1.46

0.56

7.1

2.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.46

0.56

8.0

8.4

4.67

6.06

pmol/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1.46

0.56

1.8

1.7

3.63

iu/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.63

0.55

2.0

1.2

—

(4268621) Lupus anticoagulant assay

1.63

0.55

2.0

2.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.63

0.55

3.7

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

186

1.31

0.55

1.7

1.6

1091.06

1123.89

nmol/l

0.06

141

(3014148) Varicella zoster virus Ab [Titer] in Serum

124

0.64

0.55

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.59

0.54

2.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

125

1.37

0.54

1.1

1.5

0.70

3.32

u/ml

1.51

(3019230) Fractional oxyhemoglobin in Venous blood

108

1.40

0.53

17.9

18.9

69.00

68.58

0.03

108

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

126

1.36

0.52

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

126

1.36

0.52

1.2

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

568

1.17

0.52

2.0

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.51

0.51

10.2

7.4

—

(3000494) Fungus identified in Specimen by Culture

344

1.21

0.51

1.7

2.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.48

0.51

1.2

2.4

—

(3002032) Base excess in Venous blood by calculation

789

1.14

0.50

10.7

10.6

0.14

1.14

mmol/l

1.07

638

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.44

0.49

3.3

4.7

82.55

5.34

u/ml

0.48

(40768446) Kidney Pathology biopsy report

1.56

0.49

2.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

281

1.23

0.49

1.4

3.22

3.17

ratio

0.09

179

(44816559) Phosphatidylethanol [Mass/volume] in Blood

190

1.28

0.49

1.3

1.7

0.20

0.19

mg/l

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

216

2046

1.11

0.49

4.5

3.8

55.34

46.85

ug/l

0.37

208

1961

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

346

1.20

0.48

8.3

7.1

2266.57

776.72

ng/l

0.85

292

(3034770) Mitochondria Ab [Titer] in Serum

1.41

0.48

1.4

2.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.53

0.48

4.4

6.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.53

0.48

1.7

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.46

0.48

3.0

5.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

792

1.14

0.48

2.1

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.50

0.47

2.0

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

158

1687

0.90

0.47

1.7

1.9

0.78

3.06

u/ml

3.06

332

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

204

1930

1.11

0.47

3.3

2.8

1.10

1.06

mmol/l

0.35

197

1830

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

231

0.77

0.46

1.2

1.1

1.06

1.29

u/ml

—

113

(3006504) Eosinophils/Leukocytes in Blood

221

2101

1.10

0.46

9.7

10.0

2.84

3.19

1.51

216

2000

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.44

0.46

1.5

1.4

—

(3044889) 12 lead EKG panel

167

1567

1.11

0.45

2.5

2.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.46

0.44

1.5

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

344

3349

1.12

0.44

10.5

9.5

25.77

24.01

u/l

0.87

334

3250

(3006598) pH of Arterial cord blood

0.63

0.42

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.63

0.42

1.0

18.50

19.17

mmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

304

0.81

0.42

1.6

1.4

—

(3019069) Monocytes/Leukocytes in Blood

221

2108

1.10

0.42

9.8

10.0

8.43

8.45

0.05

216

2003

(3020682) Albumin/Creatinine [Ratio] in Urine

324

1.19

0.42

5.5

4.8

5.96

6.69

mg/mmol

0.08

267

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.52

0.41

2.4

342.20

1128.06

u/ml

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.52

0.41

3.0

2.6

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.41

0.0

4.7

—

4.56

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.41

0.0

2.6

—

3.78

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

1.59

—

(3032641) Amino acids panel - Urine

0.00

0.41

0.0

1.2

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

0.41

0.0

6.4

—

44.28

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

114

1.33

0.41

2.1

4.5

583.11

531.00

e6/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

150

1.28

0.40

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.48

0.40

1.2

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

735

1.12

0.40

10.6

10.3

22.98

23.63

mmol/l

1.20

735

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

236

2262

1.09

0.39

2.8

2.5

5.52

5.34

mmol/l

0.70

215

2072

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

106

1.33

0.39

1.1

1.3

199.83

314.36

iu/ml

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.39

0.0

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.2

—

197.98

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

1352.11

—

(3002523) Influenza virus A Ag [Presence] in Specimen

151

1.27

0.39

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

440

1.15

0.38

2.8

2.4

14432.04

8559.66

u/l

—

128

(3025018) Bordetella pertussis Ab [Titer] in Serum

136

0.73

0.38

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

107

1152

0.91

0.37

2.9

2.6

—

(1616796) Gas panel - Central venous blood

1.37

0.36

2.9

5.9

—

(44813793) Dust mix specific IgE antibody measurement

1.27

0.36

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

330

0.84

0.36

1.5

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

162

1.25

0.36

20.0

20.1

93.85

95.66

0.30

162

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.43

0.35

2.7

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.37

0.34

3.8

3.1

53.67

59.14

umol/l

—

(3011412) CD3 cells [#/volume] in Blood

118

1.28

0.34

2.1

4.6

1332.56

1413.00

e6/l

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

427

1.14

0.33

6.7

7.4

5.25

6.38

umol/l

0.55

357

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.66

0.33

1.2

—

13.32

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

369

0.86

0.33

1.3

1.2

2.30

2.51

u/ml

0.07

265

(3016018) Differential panel - Cerebral spinal fluid

1.36

0.32

5.0

4.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.28

0.32

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

110

1.28

0.32

1.4

2.2

—

(3003694) ABO and Rh group [Type] in Blood

107

1141

0.92

0.31

1.9

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

1.26

0.30

2.2

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

364

1.14

0.29

6.0

5.6

61.76

63.28

e9/l

0.10

220

(40758558) Short blood count panel - Blood

139

1319

1.08

0.28

6.6

8.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

140

0.78

0.28

1.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

112

1.26

0.28

2.1

1.8

—

(21494755) Public health laboratory ask at order entry panel

193

0.82

0.27

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

832

1.09

0.26

2.7

3.5

60.45

102.23

ug/g

2.11

670

(3014576) Chloride [Moles/volume] in Serum or Plasma

349

1.13

0.26

17.8

15.1

105.59

105.38

mmol/l

0.11

349

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

350

0.88

0.25

2.2

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

114

1.24

0.25

2.1

4.8

0.22

0.35

e9/l

—

(3011648) Oxygen content in Venous blood

1.20

0.25

28.2

23.5

10.51

11.52

—

(3010421) pH of Blood

1.20

0.25

3.2

7.2

7.39

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

113

1191

0.93

0.25

3.1

2.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

161

1.19

0.24

20.7

20.2

0.65

0.69

0.27

161

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.72

0.24

1.0

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

817

1.08

0.23

18.8

15.9

24.68

24.73

mmol/l

0.05

817

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

115

1.22

0.23

2.1

4.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

525

1.10

0.23

3.3

2.4

21.41

24.88

ng/l

0.14

190

(3000850) Epithelial cells [#/volume] in Urine

779

1.08

0.23

4.3

3.5

7.00

7.92

e6/l

0.27

702

(3023430) Cat dander IgE Ab [Units/volume] in Serum

242

0.86

0.23

1.1

26.49

11.97

u/ml

0.31

155

(3013336) Amino acids [Identifier] in Serum or Plasma

1.28

0.23

3.8

2.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1.28

0.23

2.2

4.4

48.52

23.55

ug/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

316

3100

1.07

0.23

4.7

4.2

1.92

1.96

mu/l

0.23

300

2946

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.26

0.22

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1.25

0.22

10.8

3.1

1.07

1.23

mmol/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.25

0.22

1.8

1.3

97.20

126.10

pmol/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

430

1.10

0.22

1.5

2.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

557

1.09

0.21

8.7

6.6

31.88

30.72

0.64

550

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.19

0.21

1.0

1.7

168.80

124.36

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

57.80

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

55.80

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.21

0.0

2.9

—

277.20

—

(3034426) Prothrombin time (PT)

0.00

0.21

0.0

1.2

—

26.80

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

18.0

—

27.18

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

16.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

102

0.78

0.21

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

102

0.78

0.21

1.3

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

7.9

—

4.06

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

185

1790

1.06

0.21

10.9

7.9

6.29

6.05

mmol/l

0.55

176

1679

(3045788) Cell count panel - Pleural fluid

0.00

0.21

0.0

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

336

1.11

0.20

2.1

2.4

4.45

7.43

iu/l

3.08

216

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

176

0.85

0.20

1.1

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

2.2

—

180.64

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.20

0.0

2.7

—

106.57

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.20

0.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.20

0.0

2.7

—

1.22

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

191

1966

0.95

0.20

2.3

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.22

0.19

1.3

1.8

—

(3013512) EKG study

492

1.09

0.19

2.6

2.4

—

(3051651) Icteric interference index of Serum or Plasma

1.18

0.19

7.0

4.8

1.00

0.49

index

—

(3008898) HLA-B27 [Presence]

206

0.87

0.18

1.0

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

153

0.84

0.18

8.4

5.8

123.31

175.89

ng/l

0.42

142

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

416

1.09

0.18

5.5

3.3

1246.45

1261.29

ng/l

0.01

224

(3027315) Oxygen [Partial pressure] in Blood

1.21

0.18

3.4

8.0

7.96

9.16

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.21

0.18

3.3

8.0

5.70

4.85

kpa

—

(21494815) CD4 cells/Lymphocytes in Specimen

110

1.19

0.17

2.2

4.8

42.60

37.10

1.20

110

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1.22

0.17

36.4

18.8

0.39

0.33

iu/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.75

0.17

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.71

0.17

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

120

1.17

0.16

1.4

1.5

56.05

57.82

ug/l

0.06

120

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

168

1.14

0.16

1.5

0.21

0.20

g/l

0.16

162

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

224

0.89

0.16

1.9

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

733

1.06

0.15

3.9

3.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.21

0.15

1.0

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.11

0.15

1.2

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

223

0.89

0.15

1.2

1.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

169

1.13

0.14

1.4

1.5

1.17

1.13

g/l

0.41

162

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.81

0.14

1.6

1.5

—

(40768443) Skin Pathology biopsy report

0.80

0.14

1.4

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

131

1.15

0.14

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

408

0.92

0.14

1.3

3.25

3.22

u/ml

0.00

287

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

203

1985

1.04

0.14

4.5

3.4

36.15

35.57

mmol/mol

0.32

194

1885

(3008401) Mugwort IgE Ab [Units/volume] in Serum

377

0.92

0.14

1.2

0.46

1.39

u/ml

1.65

264

(3017446) Testosterone [Moles/volume] in Serum or Plasma

305

1.09

0.14

1.7

2.2

10.80

8.94

nmol/l

0.31

272

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.83

0.14

1.5

1.8

2.50

5.70

ug/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.83

0.14

1.3

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.80

0.13

2.8

2.2

0.21

0.12

nmol/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

109

0.82

0.13

1.0

1.44

1.53

g/l

—

109

(3019977) pH of Arterial blood

219

1.10

0.13

18.8

15.7

7.38

7.40

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

123

1.14

0.12

1.4

1.5

16.21

17.94

u/ml

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

183

1792

1.04

0.11

3.9

4.5

27.58

25.98

u/l

0.27

169

1722

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

504

1.06

0.11

1.4

1.5

1.35

1.37

0.14

451

(3003888) Timothy IgE Ab [Units/volume] in Serum

383

0.93

0.11

1.2

7.65

7.31

u/ml

0.04

285

(3037522) Nuclear Ab [Titer] in Serum

505

0.94

0.11

1.5

1.6

920.00

455.47

titre

—

(4062490) Immunoglobulin typing, IgG

1.17

0.11

1.3

1.5

—

(3022621) pH of Urine by Test strip

208

0.91

0.10

2.4

1.9

6.00

6.34

0.93

126

(3000330) Specific gravity of Urine by Test strip

115

1.13

0.10

3.7

2.1

1.02

ratio

0.16

(1761868) Lipid panel - Serum or Plasma

792

1.04

0.10

2.5

1.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1.15

0.10

7.5

3.3

590.82

404.53

ug/l

0.44

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.14

0.10

1.0

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

174

1.10

0.09

1.9

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

399

1.06

0.09

1.3

1.2

1.83

9.21

u/ml

1.27

120

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.04

0.09

1.0

1.2

—

400.09

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1.04

0.09

4.6

3.2

20.60

49.62

u/ml

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

1.14

0.09

3.3

6.4

95.18

94.08

0.05

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

126

1.11

0.09

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.11

0.09

1.0

4.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.11

0.09

1.0

4.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

257

0.93

0.09

1.2

1.1

10.27

6.74

u/ml

0.35

168

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.07

0.08

1.0

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

224

1.08

0.08

1.2

1.4

2.89

2.96

mmol/l

0.13

132

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.80

0.08

1.0

1.7

7.57

13.83

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

154

0.91

0.08

1.6

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

362

1.05

0.08

1.6

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.80

0.07

1.0

1.4

—

184.00

—

(3016879) Cocaine [Presence] in Urine

580

1.04

0.07

1.4

1.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.03

0.07

7.6

5.7

2.52

2.04

ug/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.87

0.07

1.0

1.3

—

(3027944) Amphetamines [Presence] in Urine

619

0.96

0.07

1.5

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

482

1.04

0.07

2.3

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

538

0.96

0.07

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.89

0.07

1.5

2.1

216.38

136.77

ng/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

368

3659

1.03

0.06

4.0

3.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

109

1.10

0.06

1.8

1.0

0.94

0.80

g/l

0.38

109

(3000764) Benzodiazepines [Presence] in Urine

617

0.97

0.06

1.5

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

326

1.05

0.05

2.9

1.8

2.43

2.41

mmol/l

0.52

276

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

446

1.03

0.05

1.3

1.2

8.83

15.71

iu/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

774

0.98

0.04

2.3

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

200

0.95

0.04

1.5

1.3

275.62

216.07

miu/ml

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

218

2164

1.01

0.03

11.4

7.4

110.44

111.17

ml/min/173m2

0.16

163

1600

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

151

1.06

0.03

1.9

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

158

1565

1.01

0.03

1.7

1.8

1.48

1.55

g/l

0.31

849

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

842

0.98

0.03

2.7

2.6

—

(3025941) Bacteria identified in Stool by Culture

181

1.05

0.03

1.5

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

500

0.98

0.02

1.5

1.7

—

(3027008) Opiates [Presence] in Urine

620

0.98

0.02

1.5

1.7

—

(3035933) Granulocytes/Leukocytes in Blood

178

0.95

0.02

2.9

2.8

49.35

54.13

0.73

178

(3021879) Hepatitis B virus core Ab [Presence] in Serum

331

1.03

0.02

1.9

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.08

0.02

1.2

1.4

346.00

368.53

ug/g

—

(36660697) Celiac disease serology panel - Serum

708

0.99

0.01

1.3

—

(40768797) Stomach Pathology biopsy report

283

1.03

0.01

1.6

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

126

0.95

0.01

2.1

1.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

496

0.99

0.00

1.1

1.3

—

3.30

—

(3044640) Blood type and Crossmatch panel - Blood

886

0.99

0.00

4.6

3.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

244

0.98

0.00

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

145

1.04

0.00

1.5

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

271

1.00

0.00

1.4

2.1

—

(3042936) Bacteria identified in Isolate by Culture

357

1.01

0.00

3.7

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

765

1.01

0.00

2.4

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

198

1.01

0.00

1.3

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

119

1184

1.01

0.00

2.6

2.3

—

(3028300) Cannabinoids [Presence] in Urine

620

1.00

0.00

1.5

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

317

1.01

0.00

3.8

2.4

27.59

31.20

u/l

0.71

257

(3003327) Ova and parasites identified in Stool by Light microscopy

245

1.02

0.00

1.8

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.92

0.00

2.8

2.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.99

-0.00

1.0

1.4

106.43

82.07

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

2.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

5.1

—

138.33

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

70.40

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.87

-0.00

2.0

2.5

—

(40763791) Oxygen content in Venous blood by calculation

0.00

-0.00

0.0

22.0

—

13.62

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

-0.00

0.0

3.6

—

(3022689) Creatine [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

9.34

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.0

—

11.59

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.93

-0.00

2.6

1.9

—

(40757373) Influenza virus identified in Isolate

0.00

-0.00

0.0

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

-0.00

0.0

2.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

18.1

—

(4198724) Urine methamphetamine measurement

1.00

-0.00

1.9

1.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3016228) CD19 cells/cells in Blood

0.00

-0.00

0.0

3.8

—

13.17

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.01

-0.00

2.0

3.6

0.72

0.78

e9/l

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

75.10

—

(4024509) Urine culture

0.90

-0.00

2.1

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.88

-0.00

1.0

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.99

-0.00

3.3

1.6

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.92

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

-0.00

0.0

1.0

—

305.00

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(3016038) Potassium [Moles/volume] in Urine

1.00

-0.00

4.8

2.3

51.33

35.87

mmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

4.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

85.60

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

2.0

—

0.00

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.3

—

6.35

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

0.00

-0.00

0.0

3.8

—

29.00

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.01

-0.00

1.1

1.8

0.74

5.18

u/ml

—

(3035715) Granulocytes [#/volume] in Blood

0.97

-0.00

4.1

4.0

2.61

3.30

e9/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

9.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.3

—

1.40

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.99

-0.00

1.0

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

215.80

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.0

—

4.78

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_INFECTIONS_SPECIFIC_PERINA_PERIOD and mortality.

Females

Parameter	HR [95% CI]	p-value
P16_INFECTIONS_SPECIFIC_PERINA_PERIOD	1.84 [1.45, 2.34]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.613

During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 16734 females with P16_INFECTIONS_SPECIFIC_PERINA_PERIOD died.

Males

Parameter	HR [95% CI]	p-value
P16_INFECTIONS_SPECIFIC_PERINA_PERIOD	1.099 [0.9, 1.34]	0.351
Birth year	0.987 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 113 out of 23642 males with P16_INFECTIONS_SPECIFIC_PERINA_PERIOD died.

Mortality risk

Mortality risk for people of age

years, who have P16_INFECTIONS_SPECIFIC_PERINA_PERIOD.

N-year risk	Females	Males
1	0.158%	0.199%
5	1.081%	1.32%
10	2.695%	3.159%
15	5.399%	6.062%
20	9.582%	10.507%

Relationships between endpoints

↥

Index endpoint: P16_INFECTIONS_SPECIFIC_PERINA_PERIOD – Infections specific to the perinatal period

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Infections specific to the perinatal period

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints